A Closer Look At The Recent Literature On Infectious Diseases And Antibiotics

Warren S. Joseph DPM FIDSA
9/26/11 | 3825 reads | 0 comments
As I mentioned in a previous post, there are a number of journals I follow to stay abreast of developments in the infectious disease, microbiology and antibiotic world (see http://bit.ly/iLJb6k ). For updates on the latest in antibiotic development from pre-clinical through clinical testing, no journal beats the American Society of Microbiology’s Antimicrobial Agents and Chemotherapy (http://aac.asm.org/ ). Read More.

Why I Don’t Eat Raw Oysters: What The Emerging Literature Reveals About Infectious Diseases And Contaminated Food

Warren S. Joseph DPM FIDSA
8/25/11 | 3272 reads | 1 comments
The more I read the infectious disease literature, the more limited my diet becomes. It seems that new reports of contaminated food are published regularly. It gets to a point where you do not know what you should and should not eat. I have always been wary of raw foods and rarely eat sushi. This was especially the case after an article was published in Clinical Infectious Diseases a number of years ago complete with pictures of the worm coughed up by a patient who ate salmon sushi.1 (I apologize to those of you who love to eat sushi. It’s just not for me.) Read More.

A Pertinent Overview Of Infection Control And Instrument Disinfection

Warren S. Joseph DPM FIDSA
7/27/11 | 6198 reads | 0 comments
This week I will be giving a talk on office infection control to the podiatric assistants at the American Podiatric Medical Association (APMA) National Meeting in Boston. I believe this is an area that does not receive enough attention since it is far from “sexy” or cutting edge, but is still important. Read More.

Is Pseudomonas A Legitimate Pathogen Or A Notorious Colonizer In Lower Extremity Infections?

Warren S. Joseph DPM FIDSA
5/19/11 | 6265 reads | 3 comments
For a number of years, I have referred in my lectures to the word I have termed “Pseudomonaphobia.” Basically, this is an irrational fear of the organism Pseudomonas aeruginosa when it is isolated from a culture of a wound in the foot. I really believe this arises in most podiatrists during the residency interview process when, without fail, the interviewer asks them, “How would you treat a Pseudomonas infection in the foot?” Read More.

Do Patients Really Need Four To Six Weeks Of IV Antibiotics For Osteomyelitis?

Warren S. Joseph DPM FIDSA
4/20/11 | 4003 reads | 0 comments
I have blogged a number of times about the questions surrounding some of the unknown, unproven issues surrounding the treatment of osteomyelitis, including the duration of antibiotic therapy and the “need” for surgical debridement. It continues to amaze me how — it does not matter where or to whom I lecture — if I ask the question, “How long do you need to treat osteomyelitis and via what route?” the answer is always the same “four to six weeks of IV therapy.” This comes despite a total lack of human evidence to support that position. Read More.

The New Attack Of The Multi-Drug Resistant Organisms

Warren S. Joseph DPM FIDSA
3/30/11 | 4176 reads | 0 comments
I recently returned from the Diabetic Foot Global Conference (DFCon) in Los Angeles. This is always my favorite scientific conference of the year. (I have blogged about it previously http://www.leinfections.com/diabetic-foot/the-olmos-award-and-dfcon-2010/). Read More.

Have You Heard About The Latest Onychomycosis Product That Is ‘80 Percent Effective’?

Warren S. Joseph DPM FIDSA
3/7/11 | 4895 reads | 2 comments
I was recently quoted in a very fair and balanced article on laser treatment of onychomycosis that was published in the Wall Street Journal and written by the newspaper’s Science Reporter Laura Johannes.1 During my interview with Ms. Johannes, I bemoaned the lack of published evidence not only for laser therapy of onychomycosis but for any of the recently promoted treatments, either device or solution. Read More.

Raising Concerns About the Vancomycin Dosing Recommendations In The IDSA MRSA Guidelines

Warren S. Joseph DPM FIDSA
2/3/11 | 5815 reads | 0 comments
For part three of this posting on the new Infectious Diseases Society of America (IDSA) methicillin resistant Staphylococcus aureus (MRSA) guidelines, I would like to comment on some of the executive summary points made about vancomycin dosing recommendations. I will use a similar format as before with posting the actual text and then adding my comments in italics. Read More.

What Do The IDSA MRSA Guidelines Recommend For Bone And Joint Infections?

Warren S. Joseph DPM FIDSA
1/27/11 | 4367 reads | 0 comments
For part two of this posting on the new Infectious Diseases Society of America (IDSA) methicillin resistant Staphylococcus aureus (MRSA) guidelines, I would like to comment on some of the executive summary points made about MRSA bone and joint infections. I will use a similar format as before with posting the actual text and then adding my comments in italics. Read More.